Medical/Pharmaceuticals APAC News & Press Release Distribution

Recbio Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange

Offer Price of HK $24.80 per H Share To Raise Proceeds Up to HK$765 Million Focus on the R&D of HPV Vaccine Candidates Focus on In-house Research and Development of Novel Vaccines TAIZHOU, China, March 21, 2022 /PRNewswire/ -- The China-based novel vaccines company -Jiangsu Recbio Technology Co....

2022-03-21 14:41 4978

APA Releases Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)

WASHINGTON, March 19, 2022 /PRNewswire/ -- Today, the American Psychiatric Association (APA) released theDiagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) .The manual, which the APA has published and updated since 1952, def...

2022-03-19 02:48 4908

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

SHANGHAI and HONG KONG, March 18, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for canc...

2022-03-18 22:12 7406

Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system

HANGZHOU, China, March 18, 2022 /PRNewswire/ -- On March 18th, 2022, Venus Medtech (Hangzhou) Inc. ("Venus Medtech", 2500.HK), a leading provider of integrated solutions for structural heart disease inChina, announced the appointment ofShakeel Osman as Senior Vice President of Sales Europe, resp...

2022-03-18 20:02 5378

Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system

WH Group's Subsidiary Smithfield Foods Partners with BioCircuit Technologies to Deliver Innovative Nerve Repair Solution

HONG KONG, March 18, 2022 /PRNewswire/ -- WH Group Limited ("WH Group" or "the Company", HKEX stock code: 288) today announced that Smithfield BioScience, a unit of WH Group's subsidiary Smithfield Foods which delivers life-saving medical solutions from porcine-derived bioproducts, and BioCircuit...

2022-03-18 16:31 3810

WH Group's Subsidiary Smithfield Foods Partners with BioCircuit Technologies to Deliver Innovative Nerve Repair Solution

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership upon novel JAK1 inhibitor LNK01001

HANGZHOU, China, March 18, 2022 /PRNewswire/ -- On March 18, 2022, Lynk Pharmaceuticals Co., Ltd. (Lynk Pharmaceuticals) and Simcere (2096.HK) announced a strategic partnership to develop and commercialize a highly selective JAK1 inhibitor LNK01001 inChina. Under the terms of the agreement, Lynk...

2022-03-18 13:28 8879

CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) in Hong Kong, China

SUZHOU, China, March 18, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, announced today that the new drug application (...

2022-03-18 10:35 4324

ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021

Global sales continued to excel in Brazil, Turkey, Italy, and the Czech Republic in Q4 2021 CUPERTINO, Calif., March 18, 2022 /PRNewswire/ -- Zepp Health (NYSE: ZEPP), a global smart wearable and health technology leader, completed the final quarter of 2021 with yet another season of sharp and s...

2022-03-18 10:09 4466

ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021

CStone announced the global multi-regional registration trial of anti-PD-1 antibody nofazinlimab in combination with lenvatinib as first-line treatment for patients with advanced hepatocellular carcinoma successfully reached the prespecified enrollment target

SUZHOU, China, March 18, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the global multi-regional ...

2022-03-18 08:37 4475

Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy

SHANGHAI, March 18, 2022 /PRNewswire/ -- Harvest Integrated Research Organization ("HiRO" or the "Company") announced the completion of its Series A financing in the tens of millions of US dollars. This round of investment is led by OrbiMed, with the participation from existing shareholder, Fontu...

2022-03-18 08:00 6795

Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud

First of its kind initiative in India bringing wearable technology for post-surgery care. NEW DELHI and LONDON and SINGAPORE, March 18, 2022 /PRNewswire/ -- Manipal Hospitals, the second-largest healthcare services provider inIndia, today announced a strategic partnership with ConnectedLife buil...

2022-03-18 06:00 3140

BioVaxys Announces Bioproduction of BVX-1021 for its Pan-Sarbecovirus Program in Collaboration with The Ohio State University

VANCOUVER, BC, March 17, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it has entered into an agreement with Millipore-Sigma ("Millipore") a global Contract Development and Manufacturing Research Organization (...

2022-03-17 20:18 4671

EVERSANA unveils global price and market access solution NAVLIN by EVERSANA

Next generation price and market access platform combining data, software and insights into single ecosystem CHICAGO, March 17, 2022 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today unveiledNAVLIN by EVERSANA™, a new, compr...

2022-03-17 19:10 2262

First eye drops registered on the Australian Register of Therapeutic Goods (ARTG) to slow the progression of short-sightedness now available for children aged from 4 to 14 years old[1]

SYDNEY, March 17, 2022 /PRNewswire/ -- Aspen announced the Therapeutic Goods Administration (TGA) listing of a new medication to slow the progression of short-sightedness (myopia) in children and young teenagers. EIKANCE® 0.01% eye drops (atropine sulfate monohydrate 0.01%) are available on presc...

2022-03-17 17:00 3769

KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn

MADRID, March 17, 2022 /PRNewswire/ -- KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing round which expects to achieve5 million euros to boost its projects and consolidate itself as one of the biotech sta...

2022-03-17 15:30 4059

Henlius 2021 Annual Results: New Record in Performance, Evolving to Biopharma

SHANGHAI, March 17, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its annual results for the year endedDecember 31st, 2021, sharing the company's recent noteworthy progress and achievements. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, afford...

2022-03-17 08:00 5329

Henlius 2021 Annual Results: New Record in Performance, Evolving to Biopharma

SHANGHAI, March 16, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its annual results for the year endedDecember 31st, 2021, sharing the company's recent noteworthy progress and achievements. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, afford...

2022-03-16 23:46 2771

Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology

* Lunit's latest study provides evidence for Lunit SCOPE IO's ability to predict immunotherapy response * This is the first study that adopted AI technology to define the tumor immune phenotype and to demonstrate its ability in predicting treatment outcomes of anti-PD-L1 therapy SEOUL, South ...

2022-03-16 21:09 2775

Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology

Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform

NEW YORK, March 16, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics and technologies for neurological and psychiatric diseases, has entered into an agreement withColumbia University ("Columbia") and...

2022-03-16 20:38 4752

Innoforce and Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies

- Partnership enables Hibiscus BioTechnology Studio Companies access to Innoforce's advanced therapies drug development capabilities - HANGZHOU, China and ROCKVILLE, Md., March 16, 2022 /PRNewswire/ -- Innoforce, a global development and biomanufacturing company focused on Advanced Therapy Medic...

2022-03-16 19:00 2896